The trial, named STEP, was a double-blind, placebo-controlled trial, in which pulmonary arterial hypertension (PAH) patients treated with Tracleer, an oral endothelin receptor antagonist, were randomized to receive
BAY 43-9006, a novel RAF kinase and VEGFR inhibitor under investigation for the treatment of different types of cancer, combines two anticancer activities: inhibition of tumor cell proliferation
The approval covers Remodulin (treprostinil sodium) injection for subcutaneous treatment of class III primary pulmonary hypertension patients. The approval letter did not request any additional clinical trials of
The clinical research organization (CRO) will project manage a new trial that seeks to produce data suitable for an application seeking marketing approval in the US and elsewhere
The primary endpoint of the study was a change in average weekly daily spontaneous pain ratings at week three compared to baseline. Pain scores were based on an
These new data are from an open label follow-up extension of patients originally enrolled in the TEMPO trial, a 12-month study conducted in 32 centers in the US
Abilify (aripiprazole) tablets and oral solution have been approved for maintaining efficacy in patients with bipolar I disorder with a recent manic or mixed episode, who had been
New data has shown that Imvamune is expected to be effective in protecting against smallpox infection three days after just one vaccination compared to traditional vaccines, such as
Specifically, the study used Bayer Aspirin and showed a 17% reduction in the risk of a first stroke, and a 24% reduction in the risk of an ischemic
By the end of an eight-week study, patients treated with Cymbalta (duloxetine hydrochloride) 60mg once daily demonstrated significantly greater improvement in cognition when compared to those treated with
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.